miRoncol Health

Profile

miRoncol Health is a Canadian precision health company developing a microRNA based, real-time multi-cancer early risk assessment. Using microRNA biomarkers and AI-based pattern recognition, miCheckup identifies molecular signatures associated with more than a dozen common solid tumours. The test provides an accessible, affordable pre-screen that complements established screening programs and supports physician-guided follow-up. miRoncol is seeking clinical, laboratory and commercialization partners to expand access to proactive cancer risk assessment that leads to early detection internationally.

Website

mironcol.com

Contact


Event details

Date: September 8 - 10, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

<?php global $lang_id; switch ($lang_id) { case "fr": echo 'Total de 11'; break; case "pt-br": echo 'Total de 11'; break; case "es": echo 'Total de 11'; break; case "ja": echo '11 合計'; break; case "ko": echo '11 총계'; break; case "en": default: echo '11 in total'; break; } ?>